banner

Investors

At Acadia, we remain deeply committed to providing important new therapies to patients and delivering value for our stockholders. Our Investor Center is designed to provide you with convenient access to company information.

Recent News

09/02/21
SAN DIEGO --(BUSINESS WIRE)--Sep. 2, 2021-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following upcoming investor conferences: Citi’s 16 th Annual BioPharma Virtual Conference Fireside Chat Presentation: Friday, September 10, 2021 at 11:35 a.m.
09/01/21
SAN DIEGO --(BUSINESS WIRE)--Sep. 1, 2021-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Elena Ridloff , Executive Vice President and Chief Financial Officer (CFO), will be leaving the company effective September 10, 2021 to join another biopharmaceutical company.
08/05/21
SAN DIEGO --(BUSINESS WIRE)--Aug. 5, 2021-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the Canaccord Genuity 41 st Annual Growth Conference on Thursday, August 12, 2021 , at 3:00 p.m. Eastern Time . The conference will be held virtually.